8-K: Goldenwell Biotech Dismisses Auditor Amid Going Concern Doubts

Goldenwell Biotech, Inc. has dismissed its independent auditor, Michael Gillespie & Associates, PLLC, citing the auditor's report included substantial doubt about the company's ability to continue as a going concern.

Summary

• Goldenwell Biotech, Inc. (the Company) has dismissed its independent registered public accounting firm, Michael Gillespie & Associates, PLLC (Gillespie & Associates), effective September 27, 2026.
• The dismissal was recommended and approved by the Company's board of directors.
• Gillespie & Associates' reports for the years ended December 31, 2025 and 2024, and the subsequent interim period, contained no adverse opinions or disclaimers, but did state substantial doubt about the Company's ability to continue as a going concern.
• There were no disagreements between the Company and Gillespie & Associates regarding accounting principles, financial statement disclosures, or auditing procedures.
• The Company has appointed Privatco CPA Limited (Privatco) as its new independent registered public accounting firm.
• The Company has not consulted with Privatco regarding any accounting principles, audit opinions, or past disagreements prior to their engagement.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the dismissal of the auditor, especially given the going concern note, indicating potential underlying financial instability or disagreements not fully disclosed.

Positives

• The company has appointed a new independent auditor, Privatco CPA Limited, to ensure continued financial oversight.
• There were no disagreements on accounting principles or practices with the former auditor, Michael Gillespie & Associates, PLLC.

Negatives

• The company dismissed its independent auditor, Michael Gillespie & Associates, PLLC.
• The former auditor's reports for the years ended December 31, 2025 and 2024, and the subsequent interim period, indicated substantial doubt about the Company's ability to continue as a going concern.
• The company's former auditor, Gillespie & Associates, has agreed with the statements made by the company regarding the dismissal.

Risks

• Substantial doubt exists regarding Goldenwell Biotech's ability to continue as a going concern, as noted by the former auditor.
• The dismissal of an auditor, particularly when coupled with a going concern warning, can signal underlying financial distress or operational challenges.
• The transition to a new auditor may introduce initial uncertainties or delays in financial reporting processes.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. However, the auditor's report mentioning substantial doubt about the company's ability to continue as a going concern suggests a challenging future outlook.

Management Comments

• The board of directors of the Company recommended and approved of the dismissal of Gillespie & Associates.
• The Company provided Gillespie & Associates a copy of the above disclosures and requested Gillespie & Associates to furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements.

Industry Context

StockSavvy.ai notes that auditor changes, especially when accompanied by going concern warnings, are significant events that often precede or coincide with financial distress. This is a critical signal for investors to scrutinize the company's financial health and operational viability.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased uncertainty regarding the company's financial stability and future performance due to the auditor dismissal and going concern note.
• Creditors: Potential concern over the company's ability to meet its financial obligations.
• Management: Increased scrutiny and pressure to address the underlying issues contributing to the going concern warning.

Next Steps

• The company will work with its new independent registered public accounting firm, Privatco CPA Limited, for future audits.
• Investors will likely await Privatco's initial audit reports and assessments for further clarity on the company's financial standing.

Key Dates

Recommendation

The dismissal of an auditor, especially when coupled with a going concern warning, introduces significant uncertainty. While there were no stated disagreements, the situation warrants caution. A 'hold' recommendation is appropriate pending further clarity on the company's financial health and the new auditor's assessment. Investors should monitor future filings closely.

Keywords

Auditor Change, Going Concern, Financial Reporting, Accounting Firm, Corporate Governance, SEC Filing, Form 8-K